202 related articles for article (PubMed ID: 4342512)
21. Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents.
Tonelli M; Novelli F; Tasso B; Vazzana I; Sparatore A; Boido V; Sparatore F; La Colla P; Sanna G; Giliberti G; Busonera B; Farci P; Ibba C; Loddo R
Bioorg Med Chem; 2014 Sep; 22(17):4893-909. PubMed ID: 25082514
[TBL] [Abstract][Full Text] [Related]
22. Patterns of cytopathology and lysosomal enzyme release in poliovirus-infected HEp-2 cells treated with either 2-(alpha-hydroxybenzyl)-benzimidazole or guanidine HCl.
Guskey LE; Smith PC; Wolff DA
J Gen Virol; 1970 Jan; 6(1):151-61. PubMed ID: 4313397
[No Abstract] [Full Text] [Related]
23. Antiviral activity of naphthoquinones. I. Lapachol derivatives against enteroviruses.
Pinto AV; Pinto Mde C; Lagrota MH; Wigg MD; Aguiar AN
Rev Latinoam Microbiol; 1987; 29(1):15-20. PubMed ID: 2820010
[No Abstract] [Full Text] [Related]
24. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.
De Palma AM; Thibaut HJ; van der Linden L; Lanke K; Heggermont W; Ireland S; Andrews R; Arimilli M; Al-Tel TH; De Clercq E; van Kuppeveld F; Neyts J
Antimicrob Agents Chemother; 2009 May; 53(5):1850-7. PubMed ID: 19237651
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiviral assays of some benzimidazole nucleosides and acyclonucleosides.
Garuti L; Roberti M; Gentilomi G
Farmaco; 2001 Nov; 56(11):815-9. PubMed ID: 11765032
[TBL] [Abstract][Full Text] [Related]
26. Alkylated pyrimidine derivatives as antiviral agents. I. Syntheses and antiviral screening of alkylpyrimidine and 5-alkyluracil nucleoside.
Muraoka M; Takada A; Ueda T
Chem Pharm Bull (Tokyo); 1970 Feb; 18(2):261-8. PubMed ID: 4314619
[No Abstract] [Full Text] [Related]
27. [Antiviral activity of imidazole derivatives. IV. Sensitivity of different viruses].
Tonew M; Tonew EM; Zöpel P
Arch Gesamte Virusforsch; 1971; 34(3):250-4. PubMed ID: 4330139
[No Abstract] [Full Text] [Related]
28. SYNTHESIS AND VIRUS-INHIBITORY ACTIVITY OF D- AND L-ISOMERS OF 2-(ALPHA-HYDROXY-BENZYL)-BENZIMIDAZOLE.
KADIN SB; EGGERS HJ; TAMM I
Nature; 1964 Feb; 201():639-40. PubMed ID: 14160675
[No Abstract] [Full Text] [Related]
29. Synthesis and antiviral activity of some N-benzenesulphonylbenzimidazoles.
Garuti L; Roberti M; Cermelli C
Bioorg Med Chem Lett; 1999 Sep; 9(17):2525-30. PubMed ID: 10498201
[TBL] [Abstract][Full Text] [Related]
30. Antiviral agents. 5H-as-Triazino(5,6-b) indoles.
Gladych JM; Hornby R; Hunt JH; Jack D; Boyle JJ; Ferlauto RJ; Haff RF; Kormendy CG; Stanfield FJ; Stewart RC
J Med Chem; 1972 Mar; 15(3):277-81. PubMed ID: 4333824
[No Abstract] [Full Text] [Related]
31. Antiviral activity of gliotoxin.
Larin NM; Copping MP; Herbst-Laier RH; Roberts B; Wenham RB
Chemotherapy; 1965; 10(1):12-23. PubMed ID: 4285752
[No Abstract] [Full Text] [Related]
32. Dependence of echovirus 9 on the enterovirus RNA replication inhibitor 2-(alpha-Hydroxybenzyl)-benzimidazole maps to nonstructural protein 2C.
Hadaschik D; Klein M; Zimmermann H; Eggers HJ; Nelsen-Salz B
J Virol; 1999 Dec; 73(12):10536-9. PubMed ID: 10559374
[TBL] [Abstract][Full Text] [Related]
33. Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses.
Heinz BA; Vance LM
J Virol; 1996 Jul; 70(7):4854-7. PubMed ID: 8676522
[TBL] [Abstract][Full Text] [Related]
34. Studies on the inactivation of viruses by ethylene oxide.
Hoff-Jorgensen R; Lund E
Acta Vet Scand; 1972; 13(4):520-7. PubMed ID: 4642530
[TBL] [Abstract][Full Text] [Related]
35. Antivirals. 1. 2-(Alpha-hydroxybenzyl)imidazo(4,5-C)pyridine.
Berner H; Reinshagen H
J Med Chem; 1973 Nov; 16(11):1296-8. PubMed ID: 4355925
[No Abstract] [Full Text] [Related]
36. Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses.
Schleicher JB; Aquino F; Rueter A; Roderick WR; Appell RN
Appl Microbiol; 1972 Jan; 23(1):113-6. PubMed ID: 4333892
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of viruses by phenethyl alcohol at temperatures below and above 0 degrees C.
Roihel VM; Zeitlyonok NA
Acta Virol; 1969 Mar; 13(2):139-41. PubMed ID: 4389654
[No Abstract] [Full Text] [Related]
38. Development of resistance to antiviral drugs.
Renis HE; Buthala DA
Ann N Y Acad Sci; 1965 Jul; 130(1):343-54. PubMed ID: 4285582
[No Abstract] [Full Text] [Related]
39. The characteristic and relationships of virus resistance and dependence to guanidine and other compounds.
Ferrari W; Loddo B; Gessa GL
Ann N Y Acad Sci; 1965 Jul; 130(1):404-8. PubMed ID: 4285586
[No Abstract] [Full Text] [Related]
40. [In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].
Tonew M; Tonew E; Oehring H; Schmidt J
Virologie; 1985; 36(2):111-7. PubMed ID: 2994289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
